Diagnosis and treatment of neurofibromatosis type 1 with malignant transformation and multiple gastrointestinal stromal tumors: a case report and literature review - Top-Institutions - MDSpire

Diagnosis and treatment of neurofibromatosis type 1 with malignant transformation and multiple gastrointestinal stromal tumors: a case report and literature review

  • By

  • Huabin Wang

  • Jie Liu

  • Bin Huang

  • Zhengwei Lai

  • Yanfei Fang

  • Guomiao Fu

  • June 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Sarcoma
    • Gastrointestinal Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Sarcoma
    • Gastrointestinal Oncology

  • #3

    National NF1 Service
    National NF1 Service

    London, England

    Key Differentiators

    • Oncology
    • Genetics

  • #4

    Osaka University Hospital
    Osaka University Hospital

    Osaka, Japan

    Key Differentiators

    • Oncology
    • Dermatology

  • #5

    Ludwig-Maximilians-University of Munich
    Ludwig-Maximilians-University of Munich

    Munich, Germany

    Key Differentiators

    • Oncology
    • Pathology

Original Source(s)

Diagnosis and treatment of neurofibromatosis type 1 with malignant transformation and multiple gastrointestinal stromal tumors: a case report and literature review

  • by Huabin Wang, Jie Liu, Bin Huang, Zhengwei Lai, Yanfei Fang, Guomiao Fu

  • June 1, 2026

Related Content

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

Ultraviolet radiation as a double-edged regulator of melanocyte function in vitiligo therapy and melanoma carcinogenesis

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment